Centocor Seeks Continuing Damages Over Humira
Centocor Ortho Biotech Inc. has filed a new suit against Abbott Laboratories, seeking continuing damages as Abbott appeals a $1.85 billion judgment that its arthritis treatment Humira infringes a patent held...To view the full article, register now.
Already a subscriber? Click here to view full article